| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Tramadol hydrochloride |
Is a |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Zolamine |
Is a |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ethoheptazine |
Is a |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prodipidine |
Is a |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Phenyramidol (substance) |
Is a |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levomepromazine hydrochloride |
Is a |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| chlorhydrate de benzydamine |
Is a |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Non-steroidal anti-inflammatory agent |
Is a |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by co-proxamol |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional non-opiate analgesic overdose |
Causative agent (attribute) |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Deliberate overdose of paracetamol (disorder) |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by nonopioid analgesic |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental acetaminophen poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional paracetamol poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen poisoning of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional acetaminophen and dextropropoxyphene poisoning |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen and dextropropoxyphene poisoning of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental poisoning by co-proxamol |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional poisoning by co-proxamol |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by co-proxamol of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Non-opioid analgesic adverse reaction |
Causative agent (attribute) |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adverse reaction to acetaminophen |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Non-opioid analgesic allergy |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol allergy |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Overdose of nonopioid analgesic |
Causative agent (attribute) |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Acetaminophen overdose |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental paracetamol overdose (disorder) |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen overdose of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental overdose of non-opiate analgesics |
Causative agent (attribute) |
True |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Overdose of non-opiate analgesics of undetermined intent |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to acetaminophen and dextropropoxyphene |
Causative agent (attribute) |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levomepromazine maleate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Non-opioid analgesics |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 500mg soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 24 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 100 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methionine 100 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 240 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 120 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 60 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 120mg/5mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 125 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 120mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen 120mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 250mg/5mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+methionine 500mg/250mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 500mg/5mL s/f suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-codamol 8mg/500mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dihydrocodeine tartrate 10 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-proxamol 32.5mg/325mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+codeine phosphate 500mg/30mg/sachet powder (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-proxamol 32.5mg/325mg/5mL s/f suspension (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Codeine phosphate 30 mg and paracetamol 500 mg effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Codeine phosphate 30 mg and paracetamol 500 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dihydrocodeine tartrate 30 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely codeine phosphate 13.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+diphenhydramine hydrochloride 500mg/25mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Codeine phosphate 12.8 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+diphenhydramine hydrochloride 120mg/12.5mg s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+promethazine hydrochloride 120mg/1.5mg/5mL color free s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Analgesics with anti-emetics (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+metoclopramide 500mg/5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Co-codamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen 120mg paediatric soluble tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine 65 mg and paracetamol 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine 25 mg and paracetamol 450 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen compound preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Caffeine- and paracetamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dextropropoxyphene and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dihydrocodeine tartrate and paracetamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol+caffeine 500mg/65mg soluble tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Analgesic AND antipyretic product (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acetaminophen 80mg pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 325 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 650 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 80 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely paracetamol 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Non-opioid analgesics |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]